Table 4.
Steroids | Steroids Plus Cyclophosphamide | Rituximab Plus Other Immunosuppressive Drug | Global Data (All Immunosuppressive Schemes) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Complete Response Time to Response | Relapse | Complete Response | Relapse | Complete Response | Relapse | Complete Response | Time to Complete Response (Median) | Relapse | Time to Relapse | |
Collis et al113 | 48% | 19% | 77% | 14% | 59% | 4% | 65% | 5 weeks |
11% | 137 days |
Borg et al7 | – | – | – | – | 40% | – | 87% | 20 weeks |
0% (12 months follow-up) | – |
Tiede et al4 | 47% 32 days |
– | 80% 40 days |
– | 80% 65 days |
– | 61% | 14 weeks (79 days) |
– | – |
Sun et al8 | 62% | 22% | 88% | 7% | 91% | 5% | 68% | 7–10 weeks |
9.4% (7 months follow up) | – |
Mingot-Castellano et al5 | 68% | 27% | 89% | 3.7% | 88% | 3.4% | 84% | 5–7 weeks |
7.1% (13 months follow-up) | – |
Schep et al6 | 35% | 27% | 80% | 10% | 63% | 23% | 46% with first line |
10.7 weeks |
25% | 102 days |